GRN-1301

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGRN-1301

Drug Alias NameEGFR T790M neoantigen peptide vaccine (Green Peptide)EGFR T790M neoantigen peptide vaccine (BrightPath Biotherapeutics)GRN-1301

ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine +[4]

Mechanisms of ActionEpidermal growth factor receptor erbB1 modulators

TargetsEpidermal growth factor receptor erbB1

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBrightpath Biotherapeutics Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBrightpath Biotherapeutics Co Ltd

Active IndicationsN/A

Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A